Page last updated: 2024-09-02

1,2-dimyristoylphosphatidylethanolamine and miltefosine

1,2-dimyristoylphosphatidylethanolamine has been researched along with miltefosine in 1 studies

Compound Research Comparison

Studies
(1,2-dimyristoylphosphatidylethanolamine)
Trials
(1,2-dimyristoylphosphatidylethanolamine)
Recent Studies (post-2010)
(1,2-dimyristoylphosphatidylethanolamine)
Studies
(miltefosine)
Trials
(miltefosine)
Recent Studies (post-2010) (miltefosine)
2160591,33083769

Protein Interaction Comparison

ProteinTaxonomy1,2-dimyristoylphosphatidylethanolamine (IC50)miltefosine (IC50)
RAC-alpha serine/threonine-protein kinaseHomo sapiens (human)9.6

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aguilar, LF; Colina, JR; Jemiola-Rzeminska, M; Petit, K; Strzalka, K; Suwalsky, M1

Other Studies

1 other study(ies) available for 1,2-dimyristoylphosphatidylethanolamine and miltefosine

ArticleYear
In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane.
    Biochimica et biophysica acta. Biomembranes, 2019, Volume: 1861, Issue:1

    Topics: Antineoplastic Agents; Calorimetry, Differential Scanning; Dimyristoylphosphatidylcholine; Erythrocyte Membrane; Erythrocytes; Hemolysis; Humans; Lipid Bilayers; Microscopy, Electron, Scanning; Models, Molecular; Phosphatidylethanolamines; Phospholipids; Phosphorylcholine; Spectrometry, Fluorescence; Thermodynamics; X-Ray Diffraction

2019